AnalytiChem

Formed through the acquisition and integration of companies with expertise in specialized laboratory applications, AnalytiChem brings together decades of manufacturing experience and complementary product technologies. Today, the Company focuses on supporting laboratories around the world with its portfolio of specialized laboratory equipment, reagents, and consumables. AnalytiChem products are designed to enable its customers to make better measurements in analytical chemistry and microbiology. It creates the highest-quality culture media, reference materials for inorganic and organic analysis, laboratory consumables, and sample preparation equipment that support critical measurements. AnalytiChem is a global company, with a team of over 600 employees based in manufacturing, distribution, sales, and support centers across Europe, United Kingdom, Canada, United States and Australia.

Content by AnalytiChem

Redipor by AnalytiChem combining 150+ years of expertise in high quality prepared media, now manufactured in three production facilities worldwide.
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

White laboratory mouse standing in a petri dish in a laboratory, illustrating a rodent model commonly used in scientific and preclinical studies.
Learn about common challenges and proper maintenance practices for catheterized rodent models.
Hand reaching toward a glowing AI head icon on a digital network interface with connected tech symbols.
Learn why data quality, governance, and collaboration are critical to realizing AI’s potential across the drug discovery pipeline.
ands typing on an open laptop, viewed from above, against a colorful gradient background with abstract geometric network patterns.
Explore how electronic lab notebooks strengthen data integrity, collaboration, and reproducibility across today’s research environments.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue